Page last updated: 2024-10-21

phenytoin and Coronary Artery Disease

phenytoin has been researched along with Coronary Artery Disease in 2 studies

Coronary Artery Disease: Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause.

Research Excerpts

ExcerptRelevanceReference
" This case highlights the possible pharmacokinetic interaction between phenytoin intake and Tc-sestamibi, resulting in faster hepatic clearance of the radiotracer."1.48Phenytoin Could Potentially Increase Hepatic Clearance of 99mTc-Sestamibi in Myocardial Perfusion Imaging. ( Kavanal, AJ; Mittal, BR; Parmar, M; Singh, D; Sood, A, 2018)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Kavanal, AJ1
Singh, D1
Sood, A1
Parmar, M1
Mittal, BR1
Budd, SE1
Padove, LB1
Heironimus, JD1

Other Studies

2 other studies available for phenytoin and Coronary Artery Disease

ArticleYear
Phenytoin Could Potentially Increase Hepatic Clearance of 99mTc-Sestamibi in Myocardial Perfusion Imaging.
    Clinical nuclear medicine, 2018, Volume: 43, Issue:9

    Topics: Adult; Coronary Artery Disease; Hepatobiliary Elimination; Humans; Liver; Male; Metabolic Clearance

2018
Effect of dilantin on myocardial uptake of Tl-201 thallous chloride. A case report.
    Clinical nuclear medicine, 1992, Volume: 17, Issue:5

    Topics: Aged; Coronary Artery Disease; Echocardiography; Exercise Test; Heart; Humans; Male; Phenytoin; Radi

1992